$29.32
0.39[1.35%]
At close: Apr 26
$29.32
0[0.00%]
After Hours: 4:20PM EDT
Harmony Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Harmony Biosciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/30/2024 | AM | HRMY | Q1 | $0.66 | $0.62 | — | — | $119.13M | $154.80M | — | — | Get Alert |
02/22/2024 | AM | HRMY | Q4 | $1.01 | $0.48 | $0.73 | 52.08% | $128.31M | $169.06M | $168.41M | -0.38% | Get Alert |
10/31/2023 | AM | HRMY | Q3 | $0.95 | $0.65 | $0.97 | 49.23% | $117.21M | $148.87M | $160.27M | 7.66% | Get Alert |
08/01/2023 | AM | HRMY | Q2 | $0.57 | $0.62 | $0.76 | 22.58% | $107.03M | $139.79M | $134.22M | -3.99% | Get Alert |
05/02/2023 | AM | HRMY | Q1 | $0.51 | $0.47 | $0.66 | 40.43% | $85.31M | $116.79M | $119.13M | 2.00% | Get Alert |
02/21/2023 | AM | HRMY | Q4 | $0.63 | $0.58 | $1.01 | 74.14% | $91.21M | $127.34M | $128.31M | 0.76% | Get Alert |
11/01/2022 | AM | HRMY | Q3 | $0.51 | $0.13 | $0.95 | 630.77% | $80.73M | $113.54M | $117.21M | 3.23% | Get Alert |
08/02/2022 | AM | HRMY | Q2 | $0.54 | $0.44 | $0.57 | 29.55% | $73.82M | $100.75M | $107.03M | 6.23% | Get Alert |
05/03/2022 | AM | HRMY | Q1 | $0.38 | $0.29 | $0.51 | 75.86% | $59.67M | $88.55M | $85.31M | -3.66% | Get Alert |
02/28/2022 | AM | HRMY | Q4 | $0.25 | $0.37 | $0.63 | 70.27% | $56.29M | $90.01M | $91.21M | 1.34% | Get Alert |
11/09/2021 | AM | HRMY | Q3 | -$0.14 | $0.28 | $0.51 | 82.14% | $45.61M | $79.85M | $80.73M | 1.10% | Get Alert |
08/10/2021 | AM | HRMY | Q2 | — | $0.18 | $0.54 | 200.00% | — | $68.77M | $73.82M | 7.34% | Get Alert |
05/11/2021 | AM | HRMY | Q1 | — | -$0.03 | $0.38 | 1366.67% | — | $57.07M | $59.67M | 4.56% | Get Alert |
03/25/2021 | AM | HRMY | Q4 | — | $0.09 | $0.25 | 177.78% | — | $51.85M | $56.29M | 8.56% | Get Alert |
11/12/2020 | AM | HRMY | Q3 | — | -$0.05 | -$0.14 | -180.00% | — | $40.07M | $45.61M | 13.82% | Get Alert |
Harmony Biosciences (HRMY) is scheduled to report earnings on April 30, 2024. The last reported earnings were for reported on February 22, 2024 for Q4.
The Actual EPS was $0.73, which beat the estimate of $0.48.
The Actual Revenue was $168.4M, which missed the estimate of $169.1M.
Browse earnings estimates, EPS, and revenue on all stocks.